Sep 2, 2026 09:38PM
Sep 1, 2026 09:07AM
Sep 1, 2026 06:31AM
Aug 31, 2026 01:10PM
Aug 28, 2026 05:48PM
Aug 26, 2026 09:38PM
Aug 25, 2026 06:58AM Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
Aug 24, 2026 12:16PM
Aug 24, 2026 10:20AM
Aug 24, 2026 09:25AM
Aug 24, 2026 09:25AM
Aug 21, 2026 04:55PM
Aug 19, 2026 04:32PM
Aug 17, 2026 11:53AM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 14, 2026 03:43PM
Aug 14, 2026 01:13PM
Aug 14, 2026 02:50AM
Aug 13, 2026 04:05PM
Aug 13, 2026 03:41PM
Aug 11, 2026 12:18PM
Aug 10, 2026 01:44PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Aug 7, 2026 02:43PM
Aug 3, 2026 03:04PM
Jul 31, 2026 09:00AM
Jul 30, 2026 04:32PM
Jul 30, 2026 09:30AM
Jul 30, 2026 09:30AM
Jul 30, 2026 02:52AM Piper Sandler Downgrades Capricor Therapeutics (CAPR) to Neutral
Jul 29, 2026 10:05AM
Jul 29, 2026 10:05AM
Jul 29, 2026 07:45AM
Jul 27, 2026 02:36PM
Jul 27, 2026 12:31PM
Jul 27, 2026 11:02AM
Jul 27, 2026 11:00AM Capricor disputes FDA briefing materials ahead of deramiocel review
Jul 27, 2026 11:00AM
Jul 27, 2026 10:12AM
Jul 27, 2026 07:55AM
Jul 15, 2026 07:48AM
Jul 7, 2026 07:18AM
Jun 26, 2026 10:02AM
Jun 26, 2026 10:02AM Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Jun 26, 2026 09:05AM
Jun 26, 2026 09:05AM
May 13, 2026 04:15AM
May 12, 2026 04:05PM
May 8, 2026 07:15AM
Apr 22, 2026 09:02AM
Apr 22, 2026 09:00AM Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
Mar 13, 2026 07:30AM

330,685 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All